Eton Pharmaceuticals
ETON
#5394
Rank
$1.67 B
Marketcap
$58.45
Share price
-2.42%
Change (1 day)
N/A
Change (1 year)

Revenue for Eton Pharmaceuticals (ETON)

Revenue in 2026 (TTM): $0.10 Billion USD

According to Eton Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2025 the company made a revenue of $79.95 Million USD an increase over the revenue in the year 2024 that were of $39.01 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eton Pharmaceuticals from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $0.10 B32.08%
2025 $79.95 M104.94%
2024 $39.01 M23.29%
2023 $31.64 M48.9%
2022 $21.25 M-2.66%
2021 $21.83 M55879.49%
2020 $0.03 M-95.93%
2019 $0.95 M
2018 N/A